Barclays’s Core Scientific CORZ Stock Holding History

Barclays’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.68M	Buy	182,957 +26,592	+17%	+$626K	﹤0.01%	1886
2026 Q1	$2.34M	Sell	156,365 -788,172	-83%	-$13.4M	﹤0.01%	2249
2025 Q4	$13.8M	Buy	944,537 +198,192	+27%	+$3.46M	﹤0.01%	1460
2025 Q3	$13.4M	Buy	746,345 +9,561	+1%	+$140K	﹤0.01%	1471
2025 Q2	$12.6M	Buy	736,784 +499,371	+210%	+$5M	﹤0.01%	1408
2025 Q1	$1.72M	Sell	237,413 -788,154	-77%	-$8.97M	﹤0.01%	2735
2024 Q4	$14.4M	Sell	1,025,567 -144,523	-12%	-$2.14M	﹤0.01%	1305
2024 Q3	$13.9M	Buy	1,170,090 +433,855	+59%	+$4.5M	﹤0.01%	1259
2024 Q2	$6.85M	Buy	736,235 +536,235	+268%	+$2.74M	﹤0.01%	1357
2024 Q1	$708K	Buy	+200,000	New	+$694K	﹤0.01%	3364

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Barclays's CORZ Position: Q2 2026 in Review

Barclays increased its Core Scientific (CORZ) stake by 17% in Q2 2026, buying an estimated $626K and bringing the position to 182,957 shares worth $4.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1886.

Barclays first reported a position in CORZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $14.4M in Q4 2024. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Barclays held 182,957 shares of Core Scientific worth $4.68M as of Q2 2026.
Barclays bought 26,592 Core Scientific shares in Q2 2026, an estimated $626K.
Core Scientific made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1886 holding.
Barclays first reported a position in Core Scientific in Q1 2024 and has held it in 10 quarters since.
Barclays's Core Scientific position peaked at $14.4M in Q4 2024.
412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.